Avellino launches DNA test for LASIK safety

Article

Avellino Lab USA recently launched the Avellino DNA Dual Test for LASIK Safety, a genetic test that can detect both Granular Corneal Dystrophy (GCD) type 1 and Avellino Corneal Dystrophy (also known as GCD2).

Menlo Park, CA-Avellino Lab USA recently launched the Avellino DNA Dual Test for LASIK Safety, a genetic test that can detect both Granular Corneal Dystrophy (GCD) type 1 and Avellino Corneal Dystrophy (also known as GCD2).

GCD is one of the more well-known corneal dystrophies related to genetic mutations. If a patient with GCD1 undergoes vision correction surgery (e.g. LASIK, LASEK, PRK), he is at extreme risk of experiencing eventual blindness. Many patients do not show physical symptoms of the condition until later in life, so relying solely on a visual examination and family history can put patients at risk, the company says.

The Avellino DNA Dual Test is able to detect the presence of the genetic mutation for GCD, allowing the patient to take precautionary steps to postpone the progression of the condition, including avoiding vision correction surgery.

Next:Hoya introduces Sensity, light reactive lenses

Adlens presents Adlens Sundials

DrFirst, My Vision Express partner to deliver comprehensive e-Rx to ECPs

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
© 2025 MJH Life Sciences

All rights reserved.